- Lobbying
- Corey AND Malmgren
Lobbying Arrangements Results for 'Corey Malmgren'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to infectious disease. |
CorMedix, Inc.
|
Tiber Creek Group | |||
Details Issues related to cancer screenings. |
Delfi Diagnostics
|
Tiber Creek Group | |||
Details Issues related to IP protection under Bayh Dole; issues related to implementation of drug pricing and reimbursement for prescription drugs related to the Inflation Reduction Act of 2022 (PL 117-169). |
Pharmaceutical Industry Labor Management Association
|
Tiber Creek Group | |||
Details Issues related to multi-cancer early detection screening; H.R. 2407 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. |
GRAIL, LLC
|
Tiber Creek Health Strategies, Inc. | |||
Details H.R. 1406/S.3021 - Sustainable Cardiopulmonary Rehabilitation Services in the Home Act. |
Recora
|
Tiber Creek Group | |||
Details Issues related to Valley fever; H.R. 6227/S.3220 - Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023; H.R. 6731/S.3464, the FORWARD Act. |
Anivive Lifesciences Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). |
Daiichi Sankyo, Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B... |
Merck & Co., Inc
|
Tiber Creek Group | |||
Details Issues related to Medicare reimbursement. |
Fresenius Medical Care North America
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to value-based health care, including the Medicare Shared Savings Program (MSSP) and the ACO Reach Program; Issues related to reforming physician payments and the Medicare Access and... |
Agilon Health, Inc.
|
Tiber Creek Group | |||
Details Issues related to drug pricing; Issues related to face-to-face meetings to improve oversight of agency commitments: issues relating to cancer research; Issues related to diabetes research. Issues r... |
Vertex Pharmaceuticals
|
Tiber Creek Group | |||
Details Issues related to value-based health care; Issues related to reforming physician payments and the Medicare Access and CHIP Reauthorization Act (MACRA) (PL 114-10); Issues related to H.R.5013/S.3503... |
Accountable for Health
|
Tiber Creek Group | |||
Details Issues related to Medicare reimbursement for opioid alternative treatments, including H.R. 3259 & S. 586 - NOPAIN Act. Issues related to U.S. Department of Veteran Affairs contracting practices. |
Smiths Group plc
|
Tiber Creek Group | |||
Details Issues related to Medicare Advantage and Medicaid; Issues related to CMS' Medicare Advantage and Medicare Part D policy and technical proposed rule. |
MMM Healthcare
|
Tiber Creek Group | |||
Details Issues related to global supply chains. |
Zymergen Inc.
|
Tiber Creek Group | |||
Details Issues related to Medicare reimbursement for opioid alternative treatments, including H.R. 3259 & S. 586 - NOPAIN Act. |
InfuSystems Holdings, Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; issues related t... |
Organon, LLC
|
Tiber Creek Group | |||
Details Issues related to drug pricing reforms; Implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues impacting rare disease treatments, including rare disease research incentives. Iss... |
Acadia Pharmaceuticals, Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169). |
McDermott Will & Emery LLP (obo Alnylam Pharmaceuticals)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B... |
Incyte Corporation
|
Tiber Creek Group | |||
Details Issues related to reproductive assistance. Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act (PL 117-169); Issues rel... |
EMD Serono, Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA. Issues related to implementation of... |
Bristol Myers Squibb
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). |
Takeda Pharmaceuticals America, Inc.
|
Tiber Creek Group | |||
Details Issues related to intellectual property protections for COVID-19 vaccines and treatments. Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation ... |
Gilead Sciences, Inc.
|
Tiber Creek Group | |||
Details Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Implementation of Inflation Reduction Act of 2022 (PL 117-169); H.R. 5378 - Lower Costs, More Transpare... |
Association for Clinical Oncology
|
Tiber Creek Group | |||
Details Issues related to Medicare Advantage and provider directories; Issues related to mental health; H.R.3417 - FAIR Act; S. 1869 - SITE Act; affordability and hospital consolidation issues; Puerto Rico... |
Elevance Health, Inc. (fka Anthem Inc.)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B... |
Alnylam Pharmaceuticals, Inc.
|
Tiber Creek Group | |||
Details H.R. 5388/S. 2740 - PREPARE Act of 2021, issues relating to Domestic API production. |
Phlow Corporation
|
Tiber Creek Group | |||
Details Issues related to FDA, Medicare reimbursement, cancer screening, workforce shortages and artificial intelligence. |
Siemens Healthineers
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to IP pro... |
Astellas Pharma US, Inc.
|
Tiber Creek Group | |||
Details Issues related to access to non-emergency medical transportation services; Issues related to home and community-based care. |
ModivCare Solutions, LLC
|
Tiber Creek Group | |||
Details Issues related to insurance coverage, prescription drugs, and telemedicine; H.R. 3801 - Employer Reporting Improvement Act, issues related to employer reporting requirements. Issues related to Medi... |
National Association of Benefits and Insurance Professionals (fka NAHU)
|
Tiber Creek Group | |||
Details Issues related to managed care pharmacists; S. 723/H.R. 1458 - Access to Prescription Digital Therapeutics Act of 2023; H.R.2666 - the Medicaid VBPs for Patients (MVP). |
Academy of Managed Care Pharmacy
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA, Consolidated Appropriations Act, 20... |
BeiGene USA, Inc.
|
Tiber Creek Group | |||
Details Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Short... |
The Ickes and Enright Group (on behalf of Greater New York Hospital Association)
|
Tiber Creek Group | |||
Details Issues related to drug pricing and reimbursement for prescription drugs, Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). Issues relating to drug pricing; Issue... |
Tiber Creek Health Strategies, Inc. (on behalf of Eli Lilly and Company)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B... |
AstraZeneca
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B... |
PHRMA
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); S. 476 - Maintaining Investments in New Innovation Act. Is... |
Tiber Creek Health Strategies, Inc. (On behalf of Novartis)
|
Tiber Creek Group | |||
Details Issues impacting hospital and physician reimbursement. FEMA reimbursement issues related to hospitals and the federal COVID response; Provider reimbursement and workforce issues. |
The Ickes & Enright Group (Northwell Health fka North Shore-LIJ)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs provision in Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D drug rebates; ... |
Amgen, Inc.
|
Tiber Creek Group | |||
Details H.R. 3, (117th Cong.) Elijah E. Cummings Lower Drug Costs Now Act H.R. 19, (117th Cong.) Lower Costs, More Cures Act of 2021 H.R. 830, Help Ensure Lower Patient (HELP) Copays Act H.R. 1503/S. 2916,... |
Merck & Co, Inc.
|
in-house lobbying |